Cue-Based Vs. Clinician-Driven Feeding in Very Low Birthweight Infants
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Aug 21, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of feeding very low birthweight infants, who weigh less than 1500 grams. In the trial, infants will be randomly assigned to one of two groups: one group will receive feeding based on their individual cues and needs, guided by trained speech therapists and nurses, while the other group will have their feeding plans decided by their doctors based on daily assessments. The goal is to find out which method helps these infants feed better and develop more successfully.
To be eligible for this trial, infants must be between 28 and 31 weeks old at birth and have started oral feeding before they reach 33 weeks of age. However, infants with certain serious health issues, such as major congenital abnormalities or significant heart problems, will not be included in the study. Families whose infants participate can expect to be part of a structured feeding program that could help improve how their baby feeds and grows. This trial is not currently recruiting participants, but it aims to gather important information about feeding practices for very low birthweight infants.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Birthweight \< 1500 grams
- • Gestational age between 28 and 31 weeks of gestation
- • Full enteral feeding established before 32 weeks of postmenstrual age (PMA)
- • Oral feeding initiated before 33 weeks PMA.
- Exclusion criteria:
- • Major congenital/chromosomal anomalies,
- • Patent ductus arteriosus causing significant cardiovascular symptoms
- • History of necrotizing enterocolitis stage 2 or greater
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported